Your browser doesn't support javascript.
loading
Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial.
Samalin, E; Bouché, O; Thézenas, S; Francois, E; Adenis, A; Bennouna, J; Taieb, J; Desseigne, F; Seitz, J F; Conroy, T; Galais, M P; Assenat, E; Crapez, E; Poujol, S; Bibeau, F; Boissière, F; Laurent-Puig, P; Ychou, M; Mazard, T.
Afiliação
  • Samalin E; Medical Oncology Department, Institut du Cancer de Montpellier, 34298 Montpellier, France.
  • Bouché O; Medical Oncology Department, Hôpital Robert Debré, 51092 Reims, France.
  • Thézenas S; Biostatistics Department, Institut du Cancer de Montpellier, 34298 Montpellier, France.
  • Francois E; Medical Oncology Department, Centre Antoine-Lacassagne, 06189 Nice, France.
  • Adenis A; Medical Oncology Department, Centre Oscar Lambret, 59000 Lille, France.
  • Bennouna J; Medical Oncology Department, Institut de cancérologie de l'Ouest, 44805 Saint Herblain, France.
  • Taieb J; Medical Oncology Department, Assistance Publique des Hôpitaux de Paris, Hôpital Européen Georges Pompidou, 75015 Paris, France.
  • Desseigne F; Medical Oncology Department, Centre Léon Bérard, 69008 Lyon, France.
  • Seitz JF; Digestive Oncology Department Assistance Publique des Hôpitaux de Marseille, La Timone, Université de Marseille, 13005 Marseille, France.
  • Conroy T; Medical Oncology Department, Centre Alexis Vautrin, 54519 Vandœuvre-lès-Nancy, France.
  • Galais MP; Medical Oncology Department, Centre François Baclesse, 14000 Caen, France.
  • Assenat E; Medical Oncology Department, Hôpital Saint Eloi, CHRU Montpellier, 34295 Montpellier, France.
  • Crapez E; Translational Research Unit, Institut du Cancer de Montpellier, 34298 Montpellier, France.
  • Poujol S; Pharmacology Department, Institut du Cancer de Montpellier, 34298 Montpellier, France.
  • Bibeau F; Pathology Department, Institut du Cancer de Montpellier, 34298 Montpellier, France.
  • Boissière F; Pathology Department, Institut du Cancer de Montpellier, 34298 Montpellier, France.
  • Laurent-Puig P; Biochemistry Department, Hôpital Européen Georges Pompidou, 75015 Paris, France.
  • Ychou M; Medical Oncology Department, Institut du Cancer de Montpellier, 34298 Montpellier, France.
  • Mazard T; Medical Oncology Department, Hôpital Saint Eloi, CHRU Montpellier, 34295 Montpellier, France.
Br J Cancer ; 110(5): 1148-54, 2014 Mar 04.
Article em En | MEDLINE | ID: mdl-24407191
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Aromoterapia Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogênicas / Proteínas ras / Mutação Tipo de estudo: Clinical_trials Idioma: En Revista: Br J Cancer Ano de publicação: 2014 Tipo de documento: Article País de afiliação: França
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Aromoterapia Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogênicas / Proteínas ras / Mutação Tipo de estudo: Clinical_trials Idioma: En Revista: Br J Cancer Ano de publicação: 2014 Tipo de documento: Article País de afiliação: França